Mendra
Health
· Headquartered in N/A 🌍
Track Mendra
— get Health deals in free daily digest
Overview
Mendra, a newly launched biopharmaceutical company focused on rare diseases, has secured an oversubscribed $82 million Series A funding round. This financing aims to acquire, develop, and commercialize therapies for high-unmet-need indications. The round was co-led by OrbiMed, 8VC, and 5AM Ventures, with additional participation from Lux Capital and Wing VC.
Products
Loading...
Synthesising company profile
Reading press coverage to extract founders, customers, traction signals and competitive positioning…
Recent Announcements
$82M
Investors: OrbiMed, 8VC, 5AM Ventures, Lux Capital, Wing VC
Mendra, a newly launched biopharmaceutical company focused on rare diseases, has secured an oversubscribed $82 million Series A funding round. This financing aims to acquire, develop, and commercialize therapies for high-unmet-need indications. The round was co-led by OrbiMed, 8VC, and 5AM Ventures, with additional participation from Lux Capital and Wing VC.